41599 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 29
00:47 UTC
|
RY
Royal Bank of Canada
|
◎ Target | firm only | Buy | C$307.00→ C$306.00-0.3% |
|
Aug 29
00:47 UTC
|
RY
Royal Bank of Canada
|
◎ Target | firm only | Sec→ r Outperform | C$311.00→ C$312.00+0.3% |
|
Aug 29
00:47 UTC
|
RY
Royal Bank of Canada
|
◎ Target | firm only | Buy | C$310.00→ C$318.00+2.6% |
|
Aug 29
00:47 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Michael Yee ★★★☆☆ #1573 | Buy | $220.00→ $265.00+20.5% |
|
Aug 29
00:47 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Michael Schmitz not yet tracked | Buy | $240.00→ $275.00+14.6% |
|
Aug 29
00:47 UTC
|
RNG
RingCentral
|
◎ Target | Joshua Reilly ★★★☆☆ #1867 | Buy | $55.00→ $85.00+54.5% |
|
Aug 29
00:47 UTC
|
RDNT
RadNet
|
◎ Target | Andrew Mok not yet tracked | Overweight | $65.00→ $79.00+21.5% |
|
Aug 29
00:47 UTC
|
RCEL
Avita Medical
|
◎ Target | Frank Takkinen ★★☆☆☆ #2879 | Buy | $8.00→ $12.00+50.0% |
|
Aug 29
00:47 UTC
|
RBRK
Rubrik
|
◎ Target | Fatima Boolani ★★★★☆ #397 | Buy | $96.00→ $130.00+35.4% |
|
Aug 29
00:47 UTC
|
RBRK
Rubrik
|
◎ Target | James Fish ★★★☆☆ #1668 | Overweight | $91.00→ $114.00+25.3% |
|
Aug 29
00:47 UTC
|
RBRK
Rubrik
|
◎ Target | Eric Heath ★★★★☆ #675 | Overweight | $112.00→ $120.00+7.1% |
|
Aug 29
00:47 UTC
|
RBRK
Rubrik
|
◎ Target | Gray Powell ★★★★★ #304 | Buy | $109.00→ $125.00+14.7% |
|
Aug 29
00:47 UTC
|
RBRK
Rubrik
|
◎ Target | Rudy Kessinger ★★★★☆ #516 | Buy | $90.00→ $115.00+27.8% |
|
Aug 29
00:47 UTC
|
RBRK
Rubrik
|
◎ Target | Keith Bachman ★★★★☆ #802 | Outperform | $98.00→ $115.00+17.3% |
|
Aug 29
00:47 UTC
|
RBRK
Rubrik
|
◎ Target | Saket Kalia ★★★★☆ #602 | Overweight | $110.00→ $115.00+4.5% |
|
Aug 29
00:47 UTC
|
RARE
Ultragenyx Pharmaceutical
|
◎ Target | Michael Turrin ★★★☆☆ #1682 | Overweight | $46.00→ $50.00+8.7% |
|
Aug 29
00:47 UTC
|
PYPL
PayPal
|
◎ Target | Dominick Gabriele ★★★☆☆ #1739 | Hold | $62.00→ $50.00-19.4% |
|
Aug 29
00:47 UTC
|
PURR
Hyperliquid Strategies
|
◎ Target | James McIlree ★★☆☆☆ #2597 | Buy | $9.75→ $17.00+74.4% |
|
Aug 29
00:47 UTC
|
PNG
Kraken Robotics
|
◎ Target | firm only | Buy | C$13.50→ C$13.00-3.7% |
|
Aug 29
00:47 UTC
|
PNG
Kraken Robotics
|
◎ Target | firm only | Outperform | C$11.00→ C$8.00-27.3% |
|
Aug 29
00:47 UTC
|
PD
PagerDuty
|
◎ Target | Sanjit Singh ★★★★☆ #943 | Underweight | $9.00→ $10.00+11.1% |
|
Aug 29
00:47 UTC
|
PD
PagerDuty
|
◎ Target | Kingsley Crane ★★★★☆ #813 | Buy | $10.00→ $15.00+50.0% |
|
Aug 29
00:47 UTC
|
P
Everpure
|
◎ Target | Nehal Chokshi ★★☆☆☆ #2385 | Outperform | $90.00→ $128.00+42.2% |
|
Aug 29
00:47 UTC
|
P
Everpure
|
◎ Target | Tim Long ★★★☆☆ #1493 | Equal Weight | $84.00→ $110.00+31.0% |
|
Aug 29
00:47 UTC
|
OKTA
Okta
|
◎ Target | Shyam Patil ★☆☆☆☆ #2954 | Neutral | $110.00→ $185.00+68.2% |
|
Aug 29
00:47 UTC
|
OKTA
Okta
|
◎ Target | Gabriela Borges ★★★☆☆ #1487 | Buy | $126.00→ $203.00+61.1% |
|
Aug 29
00:47 UTC
|
NTNX
Nutanix
|
◎ Target | Tim Long ★★★☆☆ #1493 | Equal Weight | $53.00→ $75.00+41.5% |
|
Aug 29
00:47 UTC
|
NIQ
NIQ Global Intelligence
|
◎ Target | Jeffrey Meuler ★★☆☆☆ #2799 | Outperform | $17.00→ $23.00+35.3% |
|
Aug 29
00:47 UTC
|
NEXA
Nexa Resources
|
◎ Target | Orest Wowkodaw ★★☆☆☆ #2820 | Sec→ r Perform | $14.00→ $15.00+7.1% |
|
Aug 29
00:47 UTC
|
NAT
Nordic American Tankers
|
◎ Target | Liam Burke ★★☆☆☆ #2738 | Buy | $7.50→ $8.00+6.7% |
|
Aug 29
00:47 UTC
|
MRVL
Marvell Technology
|
◎ Target | Christian Schwab ★☆☆☆☆ #2956 | Buy | $217.00→ $300.00+38.2% |
|
Aug 29
00:47 UTC
|
MRVL
Marvell Technology
|
◎ Target | Joseph Moore ★★☆☆☆ #2332 | Equal Weight | $224.00→ $246.00+9.8% |
|
Aug 29
00:47 UTC
|
MRVL
Marvell Technology
|
◎ Target | Rick Schafer ★★★☆☆ #2019 | Outperform | $300.00→ $325.00+8.3% |
|
Aug 29
00:47 UTC
|
MRVL
Marvell Technology
|
◎ Target | N. Quinn Bolton not yet tracked | Buy | $270.00→ $300.00+11.1% |
|
Aug 29
00:47 UTC
|
MRVL
Marvell Technology
|
◎ Target | Craig Ellis ★☆☆☆☆ #3078 | Buy | $345.00→ $315.00-8.7% |
|
Aug 29
00:47 UTC
|
MRVL
Marvell Technology
|
◎ Target | Joshua Buchalter ★☆☆☆☆ #2927 | Hold | $225.00→ $245.00+8.9% |
|
Aug 29
00:47 UTC
|
MLM
Martin Marietta Materials
|
◎ Target | Anthony Codling ★★★☆☆ #1985 | Sec→ r Perform | $610.00→ $620.00+1.6% |
|
Aug 29
00:47 UTC
|
MDT
Medtronic
|
◎ Target | Joshua Jennings not yet tracked | Buy | $100.00→ $110.00+10.0% |
|
Aug 29
00:47 UTC
|
MBRX
Moleculin Biotech
|
◎ Target | Sara Nik ★★☆☆☆ #2667 | Buy | $3.00 |
|
Aug 29
00:47 UTC
|
LUCK
Lucky Strike Entertainment
|
◎ Target | Steven Wieczynski ★★★☆☆ #1050 | Buy | $9.00→ $8.00-11.1% |
|
Aug 29
00:47 UTC
|
LMRI
Lumexa Imaging
|
◎ Target | Andrew Mok not yet tracked | Overweight | $9.00→ $13.00+44.4% |
|
Aug 29
00:47 UTC
|
LFVN
Lifevantage
|
◎ Target | Brooks O'Neil ★★★☆☆ #1484 | Hold | $5.00→ $6.00+20.0% |
|
Aug 29
00:47 UTC
|
HRL
Hormel Foods
|
◎ Target | Max Gumport ★★★☆☆ #1776 | Neutral | $27.00→ $26.00-3.7% |
|
Aug 29
00:47 UTC
|
HPQ
HP
|
◎ Target | Tim Long ★★★☆☆ #1493 | Underweight | $19.00→ $23.00+21.1% |
|
Aug 29
00:47 UTC
|
HOC
Hochschild Mining
|
◎ Target | firm only | Buy | GBX 570→ GBX 800+40.4% |
|
Aug 29
00:47 UTC
|
HEI
Heico
|
◎ Target | John Godyn ★★★☆☆ #1837 | Buy | $429.00→ $441.00+2.8% |
|
Aug 29
00:47 UTC
|
GRG
Greggs
|
◎ Target | firm only | Hold | GBX 1,610→ GBX 1,740+8.1% |
|
Aug 29
00:47 UTC
|
GNSS
Genasys
|
◎ Target | Edward Woo ★☆☆☆☆ #3212 | Buy | $6.00→ $5.00-16.7% |
|
Aug 29
00:47 UTC
|
GENB
Generate Biomedicines
|
◎ Target | Mitchell Kapoor ★★★☆☆ #1853 | Buy | $25.00→ $30.00+20.0% |
|
Aug 29
00:47 UTC
|
GAP
GAP
|
◎ Target | Jay Sole ★★★☆☆ #1894 | Buy | $40.00→ $42.00+5.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.